Endogenous Versus Exogenous Candida Endophthalmitis: Clinical Features, Risk Factors, Treatment Modalities, and Visual Outcomes
Open Access
- 10 February 2026
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 285, 218-227
Abstract
No abstract availableKeywords
Funding Information
- Research to Prevent Blindness (GR004596-1)
This publication has 53 references indexed in Scilit:
- Insights into the evolution of Candidalysin and recent developmentsArchives of Microbiology, 2025
- Utility of Ophthalmologic Screening for Patients With Candida Bloodstream InfectionsJAMA Ophthalmology, 2019
- An Outbreak of Endogenous Fungal Endophthalmitis Among Intravenous Drug Abusers in New EnglandJAMA Ophthalmology, 2017
- Persistently Vitreous Culture–Positive Exogenous Fungal EndophthalmitisAmerican Journal of Ophthalmology, 2016
- Risk Factors Predictive of Endogenous Endophthalmitis Among Hospitalized Patients With Hematogenous Infections in the United StatesAmerican Journal of Ophthalmology, 2015
- Exogenous Fungal Endophthalmitis: An Analysis of Isolates and Susceptibilities to Antifungal Agents Over a 20-Year Period (1990–2010)American Journal of Ophthalmology, 2015
- Candida glabrataEndophthalmitis Transmitted From Graft to Host After Descemet Stripping Automated Endothelial KeratoplastyJAMA Ophthalmology, 2014
- Current Thoughts in Fungal Keratitis: Diagnosis and TreatmentCurrent Fungal Infection Reports, 2013
- Endogenous Fungal Endophthalmitis: Causative Organisms, Management Strategies, and Visual Acuity OutcomesAmerican Journal of Ophthalmology, 2012
- Incidence of Acute Endophthalmitis Following Penetrating KeratoplastyArchives of Ophthalmology (1950), 2005